We focus on FDA-approved GLP-1 care pathways.
Compare manufacturer programs
If you already have a prescription, or your own doctor is writing one, manufacturer direct-to-consumer pharmacy programs are usually the most predictable self-pay option. They publish flat pricing by dose and ship directly to you.
These programs don't replace the evaluation step. A licensed clinician, your own doctor or a telehealth provider, still has to write the prescription first.
Coverage and treatment decisions involve your health history. Talk with a licensed healthcare professional before starting or changing treatment.
LillyDirect (Zepbound)
Verified Sep 11, 2026·3 official sources
PenInjection- Pricing
- Self-pay pricing for Zepbound starts at $299/month for the 2.5 mg starting dose, $399/month for 5 mg, and $449/month for 7.5 mg and higher when refilled within 45 days of the previous delivery. Outside that refill window, higher doses cost more.Source: lilly.com
- Medications listed
- Zepbound (tirzepatide) self-pay access across all FDA-approved doses, available as a multi-dose KwikPen, a single-dose pen, or a single-dose vial. LillyDirect also connects patients with independent telehealth providers who can write a prescription.Source: lilly.com
- Membership terms
- No recurring membership fee. Pricing applies per fill. The discounted rate for 7.5 mg and higher doses requires refilling within 45 days of the previous shipment.Source: lilly.com
- Trustpilot rating
- 1.7 out of 5, based on 95 reviews, specific to the LillyDirect program rather than Eli Lilly's corporate site.Source: trustpilot.com
- Years operating
- LillyDirect launched on January 4, 2024 as an Eli Lilly and Company healthcare program.Source: investor.lilly.com
- Company stage
- Emerging — the program launched in January 2024 and is operated by established manufacturer Eli Lilly and Company.Source: investor.lilly.com
NovoCare Pharmacy
Verified Aug 1, 2026·3 official sources
PillInjection- Pricing
- NovoCare Pharmacy self-pay pricing for Wegovy tablets is $149/month for 1.5 mg, $199/month for 4 mg, and $299/month for 9 mg and 25 mg. Patients new to the savings offer or NovoCare Pharmacy pay $199/month for the 0.25 mg and 0.5 mg injections for 2 monthly fills through December 31, 2026; injections are otherwise $349/month for 0.25–2.4 mg and $399/month for Wegovy HD 7.2 mg.Source: novocare.com
- Medications listed
- Ozempic and Wegovy (semaglutide) are shipped directly to patients' homes through NovoCare Pharmacy. The broader NovoCare patient-support program also covers Saxenda, Victoza, and Rybelsus.Source: novocare.com
- Membership terms
- The Wegovy Savings Offer is for patients with commercial insurance and reduces the copay to as little as $25, subject to a maximum savings of $100/month. Self-pay pricing through NovoCare Pharmacy varies by dose; the page notes that Medicare patients may be able to pay $50 a month, subject to terms.Source: novocare.com
- Years operating
- NovoCare Pharmacy launched March 5, 2025 — a program of 100-year-old Novo Nordisk, not a new pharmaceutical manufacturer. No BBB or Trustpilot profile exists specifically for the pharmacy program; the parent company's ratings are for an unrelated corporate entity and are not cited here to avoid a misleading comparison.Source: prnewswire.com
- Company stage
- Emerging — NovoCare Pharmacy launched March 2025 (about 1.5 years), though parent Novo Nordisk was founded in 1923.Source: prnewswire.com